Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if people vaccinated with the AstraZeneca Covishield vaccine batch are required to have their vaccine recognised and approved by Norway as a condition of entry.

Border restrictions are the prerogative of the receiving state. Norway will exempt travellers who are fully vaccinated with a European Medicines Agency approved vaccine from presenting evidence of a negative test on arrival, completing an entry registration form, being tested at the border or quarantining after arrival. As outlined on FCDO Travel advice, this can be evidenced by UK travellers through presenting the NHS COVID Pass with a verifiable QR code (or their Devolved Administration equivalents).

Those who have been vaccinated with one of the 5 million doses of AstraZeneca/Vaxzevria manufactured in India but deployed in the UK's rollout do not need to have their vaccine recognised separately. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised Vaxzevria and we're confident that travel to Norway should not be affected. Where there have been instances of confusion about the vaccine used in the UK, our officials have worked to clarify those misunderstandings with the governments concerned.